49 Wealth Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
49 Wealth Management's DNTH Position: Q3 2026 in Review
49 Wealth Management reduced its Dianthus Therapeutics (DNTH) stake by 4% in Q3 2026, selling an estimated $10.4K and leaving 2,413 shares worth $212K. The position accounts for 0.01% of the portfolio, ranked #210.
49 Wealth Management first reported a position in DNTH in Q1 2026 and has held it in 3 quarters since. The position peaked at $245K in Q2 2026. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- 49 Wealth Management held 2,413 shares of Dianthus Therapeutics worth $212K as of Q3 2026.
- 49 Wealth Management sold 100 Dianthus Therapeutics shares in Q3 2026, an estimated $10.4K.
- Dianthus Therapeutics made up 0.01% of 49 Wealth Management's portfolio in Q3 2026, its #210 holding.
- 49 Wealth Management first reported a position in Dianthus Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 49 Wealth Management's Dianthus Therapeutics position peaked at $245K in Q2 2026.
- 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on 49 Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.